Additionally, inhibition of EZH2 is also able to affect the macrophage activity in some other cancer types, such as suppressing macrophage infiltration in lung cancer and shifting microglia toward the M1 phenotype in glioblastoma (Yin et al., 2017; Xia et al., 2019). Here, EZH2 is linked to cancer.